Michael T McCabe
6PUBLICATIONS
68CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Aug 27, 2024
Momelotinib: Mechanism of action, clinical, and translational science.Georgios Vlasakakis, Michael T McCabe, Yu Liu Ho
|Jul 05, 2022
PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.Amish J Patel, Sarah Warda, Jesper L V Maag
|Jun 02, 2022
Chromosome-specific retention of cancer-associated DNA hypermethylation following pharmacological inhibition of DNMT1.Ashley K Wiseman, Rochelle L Tiedemann, Huihui Fan
|Nov 18, 2021
Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia.Melissa B Pappalardi, Kathryn Keenan, Mark Cockerill
|Jul 13, 2021
Fragment-based Scaffold Hopping: Identification of Potent, Selective, and Highly Soluble Bromo and Extra Terminal Domain (BET) Second Bromodomain (BD2) Inhibitors.Jonathan T Seal, Stephen J Atkinson, Paul Bamborough
|Feb 24, 2017
Loss of tumor suppressor KDM6A amplifies PRC2-regulated transcriptional repression in bladder cancer and can be targeted through inhibition of EZH2.Lian Dee Ler, Sujoy Ghosh, Xiaoran Chai
Pageof 1
Frequent Collaborators
3 joint publications
Melissa B Pappalardi
2 joint publications
Peter A Jones
1 joint publications
Lian Dee Ler
1 joint publications
Sujoy Ghosh
1 joint publications
Aye Aye Thike
1 joint publications
Ee Yan Siew
1 joint publications
Liang Kai Koh
1 joint publications
Jing Quan Lim
1 joint publications
Sandra A G Visser
1 joint publications
Pauline Ong
